Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2013-03-31
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Repeated Exposure to Umami Taste on Taste Perception, Hedonics, and Satiety
NCT03010930
Umami Taste Intensity and ad Libitum Meal Intake
NCT07059117
Sorting of Oral Sensations
NCT02390180
Study of the Neurophysiological Response to Foodstuffs
NCT06051175
Short-term Sleep Restriction on Taste Preference and Perception
NCT05524701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
200 mL tap water
Single intragastric instillation of 200 mL tap water via nasogastric tube
Single intragastric instillation of 200 mL tap water via nasogastric tube
2 g citric acid
Single intragastric instillation of 2 g citric acid in 200 mL tap water via nasogastric tube
Single intragastric instillation of 2 g citric acid in 200 mL tap water via nasogastric tube
2 g salt
Single intragastric instillation of 2 g salt in 200 mL tap water via nasogastric tube
Single intragastric instillation of 2 g salt in 200 mL tap water via nasogastric tube
0.017 g quinine
Single intragastric instillation of 0.017 g quinine in 200 mL tap water via nasogastric tube
Single intragastric instillation of 0.017 g quinine in 200 mL tap water via nasogastric tube
1 g monosodium glutamate
Single intragastric instillation of 1 g monosodium glutamate in 200 mL tap water via nasogastric tube
Single intragastric instillation of 1 g monosodium glutamate in 200 mL tap water via nasogastric tube
25 g glucose
Single intragastric instillation of 25 g glucose in 200 mL tap water via nasogastric tube
Single intragastric instillation of 25 g glucose in 200 mL tap water via nasogastric tube
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single intragastric instillation of 200 mL tap water via nasogastric tube
Single intragastric instillation of 2 g citric acid in 200 mL tap water via nasogastric tube
Single intragastric instillation of 2 g salt in 200 mL tap water via nasogastric tube
Single intragastric instillation of 0.017 g quinine in 200 mL tap water via nasogastric tube
Single intragastric instillation of 1 g monosodium glutamate in 200 mL tap water via nasogastric tube
Single intragastric instillation of 25 g glucose in 200 mL tap water via nasogastric tube
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body-mass index of \< 25
* Age 18-45 years
* no drugs
* non-smoking
Exclusion Criteria
* Substance abuse
* Regular intake of medications (except for oral contraceptives)
* Medical or psychiatric illness, especially: diabetes, pace-maker, claustrophobia
* History of gastrointestinal disorders
* Food allergies, glutamate intolerance
* Body piercings that cannot be removed
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Beglinger, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKBB 289/12/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.